Figure 2.1

Quality indicators: percentage of patients
[Download]

Figure 2.2

Patient distribution, by mean monthly hemoglobin (g/dl)
[Download]

Figure 2.3

Patient distribution, by mean monthly hemoglobin (g/dl)
[Download]

Figure 2.4

Mean monthly hemoglobin after initiation, by year
[Download]

Figure 2.5

Mean EPO dose per week after initiation, by year
[Download]

Figure 2.6

Months with IV iron in the first six months of dialysis (EPO-treated patients)
[Download]

Figure 2.7

Total IV iron dose in the first six months of dialysis (EPO-treated patients)
[Download]

Figure 2.8

A1c testing in ESRD patients with diabetes, by number of tests
[Download]

Figure 2.9

Lipid testing in ESRD patients with diabetes, by number of tests
[Download]

Figure 2.10

Diabetic eye examinations in patients with diabetes, by number of tests
[Download]

Figure 2.11

Comprehensive diabetic monitoring in ESRD patients with diabetes
[Download]

Figure 2.12

Vascular access at first outpatient dialysis
[Download]

Figure 2.13

Vascular access use at initiation, by race, 2009
[Download]

Figure 2.14

Geographic variations in the percent of hemodialysis patients using an internal access at initiation, by race & HSA, 2009
[Download]

Figure 2.15

Cumulative number of medications in Part D-enrolled ESRD patients, by race/ethnicity & low income subsidy (LIS) status, 2008
[Download]

Figure 2.16

Estimated daily number of medications in Part D-enrolled ESRD patients, by modality, race/ethnicity, & low income subsidy (LIS) status, 2008
[Download]

Figure 2.17

Part D-enrolled ESRD patients on antihypertensives, by modality & race/ethnicity, 2008
[Download]

Figure 2.18

Part D-enrolled ESRD patients using lipid lowering agents, by modality & race/ethnicity, 2008
[Download]

Figure 2.19

Part D-enrolled ESRD patients using oral vitamin D analogs, by modality & race/ethnicity, 2008
[Download]

Figure 2.20

Part D-enrolled dial. pts using phosphate binders, by modality & race/eth., 2008
[Download]

Figure 2.21

Part D-enrolled ESRD patients with diabetes using diabetes agents, by modality & race/ethnicity, 2008
[Download]

Table A

Vaccination rates (percent), by age, race/ethnicity, & modality
[Download]

Table B

Access use in prevalent dialysis patients, by age, gender, race, & ethnicity (ESRD CPM data; percent)
[Download]

Table C

Access events & complications in prevalent dialysis patients (ESRD CPM data; rate per patient year)
[Download]